Literature DB >> 15561980

The Jak-STAT pathway stimulated by interferon gamma.

Curt M Horvath1.   

Abstract

Different cytokines stimulate the Janus kinase (Jak) and signal transducer and activator of transcription (STAT) pathway. Interferon gamma (IFN-gamma) is a type II interferon that triggers antiviral and adaptive immune responses through a Jak-STAT signaling pathway. These pathways involve a similar paradigm whereby cytokine binding to the receptor activates the Jaks, which phosphorylate STATs leading to their dimerization, translocation to the nucleus, and activation of their transcription factor activity. The animation shows binding of IFN-gamma and dimerization of the receptors, activation of Jak1 and Jak2, and phosphorylation of STAT1 leading to dimerization, translocation to the nucleus, and stimulation of target gene transcription.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15561980     DOI: 10.1126/stke.2602004tr8

Source DB:  PubMed          Journal:  Sci STKE        ISSN: 1525-8882


  36 in total

1.  Knockout of the neonatal Fc receptor in cultured podocytes alters IL-6 signaling and the actin cytoskeleton.

Authors:  Pantipa Tonsawan; James Dylewski; Linda Lewis; Judith Blaine
Journal:  Am J Physiol Cell Physiol       Date:  2019-09-25       Impact factor: 4.249

2.  Interferon gamma +874 T/A polymorphism contributes to cancer susceptibility: a meta-analysis based on 17 case-control studies.

Authors:  Yuan-Yuan Mi; Qian-Qian Yu; Bin Xu; Li-Feng Zhang; Zhi-Chao Min; Li-Xin Hua; Ning-Han Feng; Yong Yao
Journal:  Mol Biol Rep       Date:  2010-12-03       Impact factor: 2.316

3.  Zelnorm, an agonist of 5-Hydroxytryptamine 4-receptor, acts as a potential antitumor drug by targeting JAK/STAT3 signaling.

Authors:  Lei Zhang; Qiaoling Song; Xinxin Zhang; Li Li; Ximing Xu; Xiaohan Xu; Xiaoyu Li; Zhuoya Wang; Yuxi Lin; Xin Li; Mengyuan Li; Fan Su; Xin Wang; Peiju Qiu; Huashi Guan; Yu Tang; Wenfang Xu; Jinbo Yang; Chenyang Zhao
Journal:  Invest New Drugs       Date:  2019-05-14       Impact factor: 3.850

Review 4.  Role of cytokines as mediators and regulators of microglial activity in inflammatory demyelination of the CNS.

Authors:  Tobias D Merson; Michele D Binder; Trevor J Kilpatrick
Journal:  Neuromolecular Med       Date:  2010-03-30       Impact factor: 3.843

Review 5.  Recent advances in understanding leptin signaling and leptin resistance.

Authors:  David L Morris; Liangyou Rui
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-09-01       Impact factor: 4.310

6.  Decidual cell regulation of natural killer cell-recruiting chemokines: implications for the pathogenesis and prediction of preeclampsia.

Authors:  Charles J Lockwood; S Joseph Huang; Chie-Pein Chen; Yingqun Huang; Jie Xu; Saeed Faramarzi; Ozlem Kayisli; Umit Kayisli; Louise Koopman; Dineke Smedts; Lynn F Buchwalder; Frederick Schatz
Journal:  Am J Pathol       Date:  2013-09       Impact factor: 4.307

7.  Loss of sarcomeric proteins via upregulation of JAK/STAT signaling underlies interferon-γ-induced contractile deficit in engineered human myocardium.

Authors:  Ren-Zhi Zhan; Lingjun Rao; Zhaowei Chen; Nicholas Strash; Nenad Bursac
Journal:  Acta Biomater       Date:  2021-03-08       Impact factor: 8.947

8.  Induction of cell cycle changes and modulation of apoptogenic/anti-apoptotic and extracellular signaling regulatory protein expression by water extracts of I'm-Yunity (PSP).

Authors:  Tze-chen Hsieh; Peili Wu; Spencer Park; Joseph M Wu
Journal:  BMC Complement Altern Med       Date:  2006-09-11       Impact factor: 3.659

9.  Vitamin C Is an Essential Factor on the Anti-viral Immune Responses through the Production of Interferon-α/β at the Initial Stage of Influenza A Virus (H3N2) Infection.

Authors:  Yejin Kim; Hyemin Kim; Seyeon Bae; Jiwon Choi; Sun Young Lim; Naeun Lee; Joo Myung Kong; Young-Il Hwang; Jae Seung Kang; Wang Jae Lee
Journal:  Immune Netw       Date:  2013-04-30       Impact factor: 6.303

10.  The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms.

Authors:  Chiara Baldini; Francesca Romana Moriconi; Sara Galimberti; Peter Libby; Raffaele De Caterina
Journal:  Eur Heart J       Date:  2021-11-07       Impact factor: 35.855

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.